Table 2 Descriptive statistics of study participants by categories of LS7 change

Total sample (n = 1022)

N (%)

121 (11.8)

686 (67.1)

215 (21.0)

Age, M (SD)

66.6 (7.0)

67.4 (7.2)

66.9 (7.5)

0.507

Female, N (%)

74 (61.2)

411 (59.9)

133 (61.9)

0.866

Years of education, M (SD)

13.5 (4.0)

13.2 (4.1)

13.4 (3.9)

0.591

MMSE score, M (SD)

29.5 (0.8)

29.3 (0.8)

29.4 (0.8)

0.192

APOE E4 carrier, N (%)

29 (24.0)

201 (29.3)

68 (31.8)

0.335

CVD, N (%)

13 (10.7)

76 (11.1)

19 (8.8)

0.646

LS7, M (SD)

9.3 (1.8)

7.8 (1.7)

6.5 (1.7)

< 0.001

BMI poor, N (%)

10 (8.3)

91 (13.3)

38 (17.7)

0.005

smoking poor, N (%)

13 (10.7)

77 (11.2)

50 (23.3)

< 0.001

physical activity poor, N (%)

3 (2.5)

85 (12.3)

47 (21.9)

< 0.001

cholesterol poor, N (%)

34 (28.1)

273 (39.8)

129 (60.0)

< 0.001

glucose poor, N (%)

5 (4.1)

39 (5.7)

14 (6.5)

0.022

blood pressure poor, N (%)

39 (32.2)

436 (63.6)

153 (71.2)

< 0.001

diet poor, N (%)

15 (12.4)

170 (24.8)

105 (48.8)

< 0.001

new antihypertensive medication at FU, N (%)

19 (15.7)

134 (19.5)

41 (19.1)

0.612

new anticholesterol medication at FU, N (%)

11 (9.1)

84 (12.2)

48 (22.3)

< 0.001

Young-old (n = 864)

N (%)

103 (11.9)

579 (67.0)

182 (21.1)

Age, M (SD)

64.3 (4.5)

65.0 (4.7)

64.3 (4.5)

0.143

Female, N (%)

64 (62.1)

340 (58.7)

114 (62.6)

0.572

Years of education, M (SD)

13.4 (4.1)

13.4 (4.0)

13.6 (3.9)

0.92

MMSE score, M (SD)

29.5 (0.8)

29.4 (0.8)

29.5 (0.7)

0.476

APOE E4 carrier, N (%)

26 (25.2)

172 (29.7)

60 (33.1)

0.402

CVD, N (%)

10 (9.7)

56 (9.7)

10 (5.5)

0.209

LS7, M (SD)

9.2 (1.8)

7.9 (1.7)

6.5 (1.8)

< 0.001

BMI poor, N (%)

9 (8.7)

77 (13.3)

30 (16.5)

0.038

smoking poor, N (%)

13 (12.6)

71 (12.3)

49 (26.9)

< 0.001

physical activity poor, N (%)

3 (2.9)

73 (12.6)

41 (22.5)

< 0.001

cholesterol poor, N (%)

29 (28.2)

232 (40.1)

109 (59.9)

< 0.001

glucose poor, N (%)

4 (3.9)

29 (5.0)

13 (7.1)

0.064

blood pressure poor, N (%)

23 (33.0)

350 (60.4)

124 (68.1)

< 0.001

diet poor, N (%)

14 (13.6)

151 (26.1)

90 (49.5)

< 0.001

new antihypertensive medication at FU, N (%)

13 (12.6)

109 (18.8)

34 (18.7)

0.311

new anticholesterol medication at FU, N (%)

9 (8.7)

66 (11.4)

39 (21.4)

0.001

Old-old (n = 158)

N (%)

18 (11.4)

107 (67.7)

33 (20.9)

Age, M (SD)

79.9 (2.2)

80.5 (3.1)

81.4 (3.1)

0.162

Female, N (%)

10 (55.6)

71 (66.4)

19 (57.6)

0.507

Years of education, M (SD)

14.1 (3.9)

11.8 (4.0)

12.4 (3.9)

0.085

MMSE score, M (SD)

29.3 (0.8)

28.9 (1.0)

29.1 (0.9)

0.299

APOE E4 carrier, N (%)

3 (16.7)

29 (27.4)

8 (24.2)

0.619

CVD, N (%)

3 (16.7)

20 (18.7)

9 (27.3)

0.519

LS7, M (SD)

9.6 (1.5)

7.6 (1.5)

6.6 (1.5)

< 0.001

BMI poor, N (%)

1 (5.6)

14 (13.1)

8 (24.2)

0.2

smoking poor, N (%)

0 (0.0)

6 (5.6)

1 (3.0)

0.648

physical activity poor, N (%)

0 (0.0)

12 (11.2)

6 (18.2)

0.145

cholesterol poor, N (%)

5 (27.8)

41 (38.3)

20 (60.6)

0.019

glucose poor, N (%)

1 (5.6)

10 (9.3)

1 (3.0)

0.208

blood pressure poor, N (%)

5 (27.8)

86 (80.4)

29 (87.9)

< 0.001

diet poor, N (%)

1 (5.6)

19 (17.8)

15 (45.5)

0.004

new antihypertensive medication at FU, N (%)

6 (33.3)

25 (23.4)

7 (21.2)

0.6

new anticholesterol medication at FU, N (%)

2 (11.1)

18 (16.8)

9 (27.3)

0.28